| SC 13G | 2020-11-27 | INTEGRATED CORE STRATEGIES (US) LLC | MyoKardia, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2020-11-10 | PRICE T ROWE ASSOCIATES INC /MD/ | MyoKardia, Inc. | 1,060,153 | 1.9% | EDGAR |
| SC 13G/A | 2020-11-10 | FMR LLC | MyoKardia, Inc. | 16,865 | 0.0% | EDGAR |
| SC 13G/A | 2020-11-10 | WELLINGTON MANAGEMENT GROUP LLP | MyoKardia, Inc. | 54,119 | 0.1% | EDGAR |
| SC 13G/A | 2020-09-10 | PRICE T ROWE ASSOCIATES INC /MD/ | MyoKardia, Inc. | 5,520,368 | 10.4% | EDGAR |
| SC 13G/A | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | MyoKardia Inc | 3,578,708 | 7.7% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | MyoKardia Inc | 3,951,583 | 8.5% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | MyoKardia Inc | 6,933,887 | 15.0% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | MyoKardia Inc | 4,142,810 | 9.0% | EDGAR |
| SC 13G/A | 2020-01-27 | WELLINGTON MANAGEMENT GROUP LLP | MyoKardia Inc | 3,490,484 | 7.6% | EDGAR |
| SC 13G/A | 2019-02-15 | Sanofi | MyoKardia Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-14 | Partner Fund Management, L.P. | MyoKardia Inc | - | 3.8% | EDGAR |
| SC 13G | 2019-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | MyoKardia Inc | 2,482,432 | 6.1% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | MyoKardia Inc | 6,040,606 | 15.0% | EDGAR |
| SC 13G/A | 2019-02-13 | Third Rock Ventures II, L.P. | MyoKardia Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | MyoKardia Inc | 2,749,065 | 6.8% | EDGAR |
| SC 13G/A | 2019-02-11 | Sanofi | MyoKardia Inc | 4,168,899 | 10.4% | EDGAR |
| SC 13G | 2019-02-11 | VANGUARD GROUP INC | MyoKardia Inc | 3,062,882 | 7.6% | EDGAR |
| SC 13G | 2019-02-08 | BlackRock Inc. | MyoKardia Inc | 2,861,588 | 7.1% | EDGAR |
| SC 13G | 2018-07-13 | Partner Fund Management, L.P. | MyoKardia Inc | - | 5.0% | EDGAR |